These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 3133335

  • 41. Modification by alpha-tocopherol, propyl gallate and tertiary butylhydroquinone of urinary bladder carcinogenesis in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Tamano S, Fukushima S, Shirai T, Hirose M, Ito N.
    Cancer Lett; 1987 Apr; 35(1):39-46. PubMed ID: 3567886
    [Abstract] [Full Text] [Related]

  • 42. Urinary bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)-nitrosamine in an analbuminemic congenic strain of rats with an ACI genetic background.
    Nagase S, Shumiya S, Takahashi M, Maekawa A, Hayashi Y.
    Jpn J Cancer Res; 1986 Dec; 77(12):1198-200. PubMed ID: 3102424
    [Abstract] [Full Text] [Related]

  • 43. The effects of catechol on the urinary bladder of rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    La Voie EJ, Shigematsu A, Mu B, Rivenson A, Hoffmann D.
    Jpn J Cancer Res; 1985 Apr; 76(4):266-71. PubMed ID: 3924700
    [Abstract] [Full Text] [Related]

  • 44. Uracil-induced calculi and carcinogenesis in the urinary bladder of rats treated simultaneously with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Okumura M, Shirai T, Tamano S, Ito M, Yamada S, Fukushima S.
    Carcinogenesis; 1991 Jan; 12(1):35-41. PubMed ID: 1988179
    [Abstract] [Full Text] [Related]

  • 45. Vascular endothelial growth factor mRNA levels as a biomarker for short-term N-butyl-N-(4-hydroxybutyl) nitrosamine-induced rat bladder carcinogenesis bioassay.
    Wakui S, Mutou T, Takahashi H, Ikegami M, Wanibuchi H, Fukushima S.
    J Appl Toxicol; 2015 Feb; 35(2):181-90. PubMed ID: 24888239
    [Abstract] [Full Text] [Related]

  • 46. Damage and repair of DNA in urinary bladder epithelium of rats treated with N-butyl-N-(4-hydroxybutyl) nitrosamine.
    Tsuda H, Miyata Y, Hagiwara A, Hasegawa R, Shirai T, Ito N.
    Gan; 1977 Dec; 68(6):781-3. PubMed ID: 598647
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Strong promoting activity of phenylethyl isothiocyanate and benzyl isothiocyanate on urinary bladder carcinogenesis in F344 male rats.
    Hirose M, Yamaguchi T, Kimoto N, Ogawa K, Futakuchi M, Sano M, Shirai T.
    Int J Cancer; 1998 Aug 31; 77(5):773-7. PubMed ID: 9688312
    [Abstract] [Full Text] [Related]

  • 52. Strong promoting activity of reversible uracil-induced urolithiasis on urinary bladder carcinogenesis in rats initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Shirai T, Tagawa Y, Fukushima S, Imaida K, Ito N.
    Cancer Res; 1987 Dec 15; 47(24 Pt 1):6726-30. PubMed ID: 3677102
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats.
    Grubbs CJ, Lubet RA, Koki AT, Leahy KM, Masferrer JL, Steele VE, Kelloff GJ, Hill DL, Seibert K.
    Cancer Res; 2000 Oct 15; 60(20):5599-602. PubMed ID: 11059745
    [Abstract] [Full Text] [Related]

  • 55. Effect of quercetin on two-stage carcinogenesis of the rat urinary bladder.
    Hirose M, Fukushima S, Sakata T, Inui M, Ito N.
    Cancer Lett; 1983 Nov 15; 21(1):23-7. PubMed ID: 6640511
    [Abstract] [Full Text] [Related]

  • 56. Aging and urinary bladder carcinogenesis induced in rats by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Fukushima S, Shibata M, Tamano S, Ito N, Suzuki E, Okada M.
    J Natl Cancer Inst; 1987 Aug 15; 79(2):263-7. PubMed ID: 3474459
    [Abstract] [Full Text] [Related]

  • 57. Lack of promotion of urinary bladder carcinogenesis by sodium bicarbonate and/or L-ascorbic acid in male ODS/Shi-od/od rats synthesizing alpha 2 mu-globulin but not L-ascorbic acid.
    Mori S, Murai T, Hosono M, Machino S, Makino S, Chou C, Fukushima S.
    Food Chem Toxicol; 1997 Aug 15; 35(8):783-7. PubMed ID: 9350223
    [Abstract] [Full Text] [Related]

  • 58. Effects of sodium saccharin and caffeine on the urinary bladder of rats treated with n-butyl-n-(4-hydroxybutyl)nitrosamine.
    Nakanishi K, Hirose M, Ogiso T, Hasegawa R, Arai M, Ito N.
    Gan; 1980 Aug 15; 71(4):490-500. PubMed ID: 7429086
    [Abstract] [Full Text] [Related]

  • 59. Strain differences in sensitivity to the promoting effect of sodium L-ascorbate in a two-stage rat urinary bladder carcinogenesis model.
    Murai T, Mori S, Hosono M, Takashima A, Machino S, Oohara T, Yamashita H, Makino S, Matsuda T, Wanibuchi H, Fukushima S.
    Jpn J Cancer Res; 1997 Mar 15; 88(3):245-53. PubMed ID: 9140108
    [Abstract] [Full Text] [Related]

  • 60. Susceptibility of p27 kip1 knockout mice to urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine may not simply be due to enhanced proliferation.
    Hikosaka A, Ogawa K, Sugiura S, Asamoto M, Takeshita F, Sato SY, Nakanishi M, Kohri K, Shirai T.
    Int J Cancer; 2008 Mar 15; 122(6):1222-8. PubMed ID: 18027869
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.